Synapse - Kenneth Yu

Search Within

Kenneth Ho-Ming Yu

Results (52)

Adjuvant modified FOLFIRINOX for resected pancreatic adenocarcinoma: Clinical insights and genomic features from a large contemporary cohort

Journal Article

Keane, F.; O’Connor, C.; Moss, D.; Chou, J. F.; Perry, M. A.; Crowley, F.; Saxena, P.; Chan, A.; Schoenfeld, J. D.; Singhal, A.; more...
JNCI: Journal of the National Cancer Institute (2025)

Fulltext@MSK | Save

Phase II trial of Pembrolizumab and OLApaRib (POLAR) maintenance for select patients (pts) with metastatic pancreatic cancer (mPC) with (A) homologous recombination deficiency (HRD), (B) non-core HRD (ncHRD) and (C) exceptional response to platinum

Meeting Abstract

Park, W.; O'Connor, C.; Chou, J.; Schwartz, C.; Larsen, M.; Varghese, A.; Yu, K.; Balogun, F.; Yang, J.; Katz, S.; more...
Annals of Oncology (2024)

Fulltext@MSK | Save

Lynch syndrome and somatic mismatch repair variants in pancreas cancer

Journal Article

O'Connor, C. A.; Harrold, E.; Lin, D.; Walch, H.; Gazzo, A.; Ranganathan, M.; Kane, S.; Keane, F.; Schoenfeld, J.; Moss, D.; more...
JAMA Oncology (2024)

Fulltext@MSK | Save

Somatic mismatch repair deficiency in pancreas cancer (PC): Immune checkpoint blockade (ICB) outcomes and exploratory genomic analyses

Meeting Abstract

O'Connor, C. A.; Harrold, E.; Lin, Y. T.; Walch, H. S.; Gazzo, A.; Kane, S. R.; Keane, F.; Schoenfeld, J. D.; Moss, D.; Suehnholz, S. P.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

Feasibility of endoscopic ultrasound-guided tissue acquisition for next-generation sequencing in pancreatic cancer patients

Meeting Abstract

Lee, S. E.; Kim, D.; Schattner, M.; Rolston, V.; Vakiani, E.; Sigel, C.; O'Reilly, E.; Yu, K.; Jarnagin, W.; Soares, K.
Gastrointestinal Endoscopy (2024)

Fulltext@MSK | Save

Clinical utility of next generation sequencing (NGS) on circulating tumor DNA (ctDNA) in patients (pts) with pancreatic cancer (PC)

Meeting Abstract

Keane, F.; Saadat, L.; O'Connor, C.; Chou, J. F.; Brannon, A. R.; Cowzer, D.; Crowley, F.; Debnath, N.; Bowman, A.; Xu, F.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Phase 2 trial of pembrolizumab and olaparib (POLAR) maintenance for patients (pts) with metastatic pancreatic cancer (mPDAC): Two cohorts B non-core homologous recombination deficiency (HRD) and C exceptional response to platinum-therapy

Meeting Abstract

Park, W.; O'Connor, C.; Chou, J. F.; Schwartz, C.; Varghese, A. M.; Larsen, M.; Balogun, F.; Brenner, R.; Yu, K. H.; Diguglielmo, E.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

A phase II study of durvalumab and stereotactic ablative body radiotherapy (SABR) in locally advanced pancreatic adenocarcinoma (LA PDAC)

Meeting Abstract

Keane, F.; Schoenfeld, J. D.; Crowley, F.; O'Connor, C. A.; White, C.; Schwartz, C.; Brenner, R.; Larsen, M.; Park, W.; Varghese, A. M.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Immunogenomic characterization of biliary tract cancers: Biomarker enrichment for benefit to immune checkpoint blockade

Meeting Abstract

Park, W.; Keane, F.; Bandlamudi, C.; Donoghue, M.; de Lara, P. T.; Harding, J. J.; Khalil, D.; McKinnell, Z.; Sterpi, M.; Cao, W.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Methylation analyses reveal promoter hypermethylation as a rare cause of “second hit” in germline BRCA1-associated pancreatic ductal adenocarcinoma

Journal Article

Zheng-Lin, B.; Rainone, M.; Varghese, A. M.; Yu, K. H.; Park, W.; Berger, M.; Mehine, M.; Chou, J.; Capanu, M.; Mandelker, D.; more...
Molecular Diagnosis and Therapy (2022)

Fulltext@MSK | Save